Michael Altorfer News Today

Swiss start-up NewBiologix is one of a growing number of companies setting up shop in Switzerland to meet the demands of gene and cell therapy makers.

Swiss biotechnology companies invested a record CHF2.6 billion into research last year despite a dip in the level of funding.

Switzerland is increasingly being challenged as a business location because of immigration restrictions. Could the pandemic be a turning point?